Movement Alert｜Hims & Hers Health Rises 5.68% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Recovery Signal Fuel Rally

Market Focus06-18 22:20

On June 18, Hims & Hers Health rose 5.68% in regular trading, trading at $34.05/share, with turnover of approximately $250 million. The stock extended its multi-session rebound driven by a combination of favorable catalysts.

On the news front, Goldman Sachs raised its global GLP-1 weight-loss drug market forecast, projecting the market to reach $114 billion by 2030, up from its prior estimate of $101 billion. The upgrade was driven by accelerating adoption of oral GLP-1 therapies, strengthening demand outside the U.S., and improving drug accessibility and affordability. As a telehealth platform with exposure to the weight management category, Hims & Hers stands to benefit from the expanding addressable market.

Additionally, recent sales tracking data showed that three out of the past four weeks delivered year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals and reigniting bullish sentiment among investors.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122673993?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 22:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122673993","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Hims & Hers Health Rises 5.68% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Recovery Signal Fuel Rally","media":"Market Focus","content":"<p><p>On June 18, Hims & Hers Health rose 5.68% in regular trading, trading at $34.05/share, with turnover of approximately $250 million. The stock extended its multi-session rebound driven by a combination of favorable catalysts.</p><p>On the news front, Goldman Sachs raised its global GLP-1 weight-loss drug market forecast, projecting the market to reach $114 billion by 2030, up from its prior estimate of $101 billion. The upgrade was driven by accelerating adoption of oral GLP-1 therapies, strengthening demand outside the U.S., and improving drug accessibility and affordability. As a telehealth platform with exposure to the weight management category, Hims & Hers stands to benefit from the expanding addressable market.</p><p>Additionally, recent sales tracking data showed that three out of the past four weeks delivered year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals and reigniting bullish sentiment among investors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hims & Hers Health Rises 5.68% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Recovery Signal Fuel Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hims & Hers Health Rises 5.68% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Recovery Signal Fuel Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-18 22:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 18, Hims & Hers Health rose 5.68% in regular trading, trading at $34.05/share, with turnover of approximately $250 million. The stock extended its multi-session rebound driven by a combination of favorable catalysts.</p><p>On the news front, Goldman Sachs raised its global GLP-1 weight-loss drug market forecast, projecting the market to reach $114 billion by 2030, up from its prior estimate of $101 billion. The upgrade was driven by accelerating adoption of oral GLP-1 therapies, strengthening demand outside the U.S., and improving drug accessibility and affordability. As a telehealth platform with exposure to the weight management category, Hims & Hers stands to benefit from the expanding addressable market.</p><p>Additionally, recent sales tracking data showed that three out of the past four weeks delivered year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals and reigniting bullish sentiment among investors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1122673993","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122673993","pubTimestamp":1781792447,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 18, Hims & Hers Health rose 5.68% in regular trading, trading at $34.05/share, with turnover of approximately $250 million. The stock extended its multi-session rebound driven by a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"运动警报|Hims&Hers Health常规交易上涨5.68%，高盛GLP-1市场升级和销售复苏信号推动反弹","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"On June 18, Hims & Hers Health rose 5.68% in regular trading, trading at $34.05/share, with turnover of approximately $250 million. The stock extended its multi-session rebound driven by a combination of favorable catalysts.On the news front, Goldman Sachs raised its global GLP-1 weight-loss drug market forecast, projecting the market to reach $114 billion by 2030, up from its prior estimate of $101 billion. The upgrade was driven by accelerating adoption of oral GLP-1 therapies, strengthening demand outside the U.S., and improving drug accessibility and affordability. As a telehealth platform with exposure to the weight management category, Hims & Hers stands to benefit from the expanding addressable market.Additionally, recent sales tracking data showed that three out of the past four weeks delivered year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals and reigniting bullish sentiment among investors.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122673993","isCrawlerRequest":true}